Skip to content

A Practical Clinical Study on the Effectiveness of Simiao Sanjie Decoction in the Treatment of High-risk Subsolid Pulmonary Nodules

A Practical Clinical Study on the Effectiveness of Simiao Sanjie Decoction in the Treatment of High-risk Subsolid Pulmonary Nodules

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400084457
Enrollment
Unknown
Registered
2024-05-16
Start date
2024-05-16
Completion date
Unknown
Last updated
2024-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Subsolid Pulmonary Nodules

Interventions

Chinese Medicine Group:Traditional Chinese medicine Si Miao Sanjie granules were treated for 6 months

Sponsors

Guang'anmen Hospital, China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Age 18-75 years old; (2) SSN with an average diameter of 6-15 mm and stable for = 3 months; (3) Consistent with the diagnosis of phlegm-dampness-depression syndrome; (4) Patients who meet the diagnostic criteria for SSN and have high-risk factors for lung cancer; (5) Meet the criteria for determining high-risk SSN; (6) Voluntarily participate in this study and sign the informed consent form;

Exclusion criteria

Exclusion criteria: (1) The total number of lung nodules = 10; (2) Patients with a history of malignancy; (3) patients who are taking oral antibiotics; (4) Patients with severe cardio-cerebrovascular or hematopoietic system diseases, or liver, kidney and other important organ lesions; (5) Children, pregnant women, mentally ill or lactating patients; (6) Patients who have received traditional Chinese medicine treatment within 1 month; (7) Patients who are allergic to the Chinese medicine they take; (8) Patients who are participating in other clinical studies; (9) Patients with a history of psychotropic drug abuse and unable to quit; (10) Patients with intellectual and mental disorders who cannot cooperate in evaluation; (11) Patients who are judged by the investigator to be unable to cooperate with the completion of the study or are not suitable for enrollment due to serious endangerment of the safety of the subjects.

Design outcomes

Primary

MeasureTime frame
Efficient;

Secondary

MeasureTime frame
Rate of progress;Stability rate;TCM syndrome evaluation;Evaluation of psychological status;

Countries

China

Contacts

Public ContactRui Liu

Guang'anmen Hospital, China Academy of Chinese Medical Sciences

drliur@126.com+86 152 1097 5095

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026